Clinical Trial Update: Circulating Tumor DNA in Patients at High Risk for Lung Cancer

View source ↗

Summary

This clinical trial update notes a terminated study investigating circulating tumor DNA as a biomarker in individuals at high risk for lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Pathway Genomics | Conditions: Cancer of the Lung, Lung Cancer | Status: TERMINATED